WallStreetZenWallStreetZen

NYSE: AVNS
Avanos Medical Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their AVNS stock forecasts and price targets.

Forecast return on equity

Is AVNS forecast to generate an efficient return?
Company
8.39%
Industry
25.39%
Market
48.93%
AVNS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AVNS forecast to generate an efficient return on assets?
Company
6.18%
Industry
13.53%
AVNS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AVNS earnings per share forecast

What is AVNS's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$1.39+717.65%
Avg 2 year Forecast
$1.82+972.53%
Avg 3 year Forecast
$2.05+1,105.88%
AVNS's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

AVNS revenue forecast

What is AVNS's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$695.1M+1.86%
Avg 2 year Forecast
$729.5M+6.9%
Avg 3 year Forecast
$764.8M+12.08%
AVNS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AVNS earnings growth forecast

How is AVNS forecast to perform vs Medical Devices companies and vs the US market?
Company
131.08%
Industry
27.66%
Market
18.87%
AVNS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
AVNS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
AVNS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

AVNS revenue growth forecast

How is AVNS forecast to perform vs Medical Devices companies and vs the US market?
Company
3.87%
Industry
7.25%
Market
9.84%
AVNS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AVNS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AVNS vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
AVNS$22.57N/AN/A
AORT$25.92$30.00+15.74%Strong Buy
BVS$12.13$14.50+19.54%Strong Buy
ESTA$39.83$59.50+49.38%Strong Buy
CATX$12.66$23.50+85.62%Strong Buy
View Top Medical Device Stocks

Avanos Medical Stock Forecast FAQ

What is AVNS's earnings growth forecast for 2024-2026?

(NYSE: AVNS) Avanos Medical's forecast annual earnings growth rate of 131.08% is forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 27.66%, and it is also forecast to beat the US market's average forecast earnings growth rate of 18.87%.

Avanos Medical's earnings in 2024 is $7,700,000.On average, 3 Wall Street analysts forecast AVNS's earnings for 2024 to be $63,869,102, with the lowest AVNS earnings forecast at $63,409,612, and the highest AVNS earnings forecast at $64,328,592. On average, 3 Wall Street analysts forecast AVNS's earnings for 2025 to be $83,778,801, with the lowest AVNS earnings forecast at $83,167,679, and the highest AVNS earnings forecast at $84,546,149.

In 2026, AVNS is forecast to generate $94,195,438 in earnings, with the lowest earnings forecast at $93,276,458 and the highest earnings forecast at $95,114,418.

If you're new to stock investing, here's how to buy Avanos Medical stock.

What is AVNS's revenue growth forecast for 2024-2026?

(NYSE: AVNS) Avanos Medical's forecast annual revenue growth rate of 3.87% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.84%.

Avanos Medical's revenue in 2024 is $682,400,000.On average, 3 Wall Street analysts forecast AVNS's revenue for 2024 to be $31,938,502,443, with the lowest AVNS revenue forecast at $31,909,738,373, and the highest AVNS revenue forecast at $31,971,310,025. On average, 3 Wall Street analysts forecast AVNS's revenue for 2025 to be $33,520,066,817, with the lowest AVNS revenue forecast at $33,496,816,626, and the highest AVNS revenue forecast at $33,551,955,419.

In 2026, AVNS is forecast to generate $35,143,398,826 in revenue, with the lowest revenue forecast at $35,122,032,544 and the highest revenue forecast at $35,164,765,108.

What is AVNS's forecast return on assets (ROA) for 2024-2027?

(NYSE: AVNS) forecast ROA is 6.18%, which is lower than the forecast US Medical Devices industry average of 13.53%.

What is AVNS's Earnings Per Share (EPS) forecast for 2024-2026?

(NYSE: AVNS) Avanos Medical's current Earnings Per Share (EPS) is $0.17. On average, analysts forecast that AVNS's EPS will be $1.39 for 2024, with the lowest EPS forecast at $1.38, and the highest EPS forecast at $1.40. On average, analysts forecast that AVNS's EPS will be $1.82 for 2025, with the lowest EPS forecast at $1.81, and the highest EPS forecast at $1.84. In 2026, AVNS's EPS is forecast to hit $2.05 (min: $2.03, max: $2.07).

What is AVNS's forecast return on equity (ROE) for 2024-2027?

(NYSE: AVNS) forecast ROE is 8.39%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.